checkAd

     145  0 Kommentare Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 - Seite 3

    INVESTOR AND MEDIA CONTACTS 
    Innovation Pharmaceuticals Inc. 
    Leo Ehrlich 
    info@ipharminc.com 


     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 - Seite 3 >60 patients have been randomized in the Company’s ~120-patient Phase 2 COVID-19 clinical trialWith COVID-19 cases rising worldwide as the coronavirus continues to mutate, the need is greater than ever to develop novel broad spectrum antivirals of …